Related Experiment Video
Updated: Sep 1, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
George K E Umanah1,2,3, Leire Abalde-Atristain1,2,4,5, Mohammed Repon Khan1,2
1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Abstract:
The mechanistic target of rapamycin (mTOR) signals through the mTOR complex 1 (mTORC1) and the mTOR complex 2 to maintain cellular and organismal homeostasis. Failure to finely tune mTOR activity results in metabolic dysregulation and disease. While there is substantial understanding of the molecular events leading mTORC1 activation at the lysosome, remarkably little is known about what terminates mTORC1 signaling. Here, we show that the AAA + ATPase Thorase directly binds mTOR, thereby orchestrating the disassembly and inactivation of mTORC1. Thorase disrupts the association of mTOR to Raptor at the mitochondria-lysosome interface and this action is sensitive to amino acids. Lack of Thorase causes accumulation of mTOR-Raptor complexes and altered mTORC1 disassembly/re-assembly dynamics upon changes in amino acid availability. The resulting excessive mTORC1 can be counteracted with rapamycin in vitro and in vivo. Collectively, we reveal Thorase as a key component of the mTOR pathway that disassembles and thus inhibits mTORC1.
Insights
The AAA+ ATPase Thorase directly binds mTOR, inhibiting mTORC1 signaling by orchestrating complex disassembly. This discovery reveals Thorase as a crucial component in regulating mTORC1 activity and cellular homeostasis.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- The mechanistic target of rapamycin (mTOR) pathway is crucial for cellular and organismal homeostasis.
- Dysregulation of mTOR activity leads to metabolic disorders.
- While mTORC1 activation is well-studied, the mechanisms terminating mTORC1 signaling remain largely unknown.
Purpose of the Study:
- To identify novel regulators of mTORC1 signaling termination.
- To elucidate the molecular mechanisms by which mTORC1 signaling is inactivated.
Main Methods:
- Biochemical assays to study protein-protein interactions.
- Cellular models to investigate mTORC1 dynamics.
- In vitro and in vivo experiments to assess Thorase function.
Main Results:
- The AAA+ ATPase Thorase directly binds to mTOR.
- Thorase facilitates the disassembly and inactivation of mTORC1 by disrupting the mTOR-Raptor interaction at the mitochondria-lysosome interface.
- Loss of Thorase leads to persistent mTORC1 signaling and altered dynamics in response to amino acid availability.
- Excessive mTORC1 signaling due to Thorase deficiency can be inhibited by rapamycin.
Conclusions:
- Thorase is a key regulator that actively disassembles and inhibits mTORC1.
- Understanding Thorase's role provides new insights into controlling mTORC1 signaling and metabolic diseases.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Destabilization of Microtubules
Amplifying Signals via Enzymatic Cascade
DNA Damage can Stall the Cell Cycle

